FDA Drug Application (202223) for VALSARTAN by AUROBINDO PHARMA LTD

Back to FDA Applications sponsored by AUROBINDO PHARMA LTD

Application Number202223
Product Number001
FormTABLET;ORAL
Dosage40MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameVALSARTAN
Active IngredientVALSARTAN

Active IngredientCount
List of drugs with Active Ingredient VALSARTAN12


Back to FDA Applications sponsored by AUROBINDO PHARMA LTD